By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Osteoporosis medicine lowers breast cancer relapse rate

Photo: APA (dpa) © Photo: APA (dpa)

"The results are spectacular“, said lead investigator Michael Gnant, Head of the University Department of Surgery at the Medical University of Vienna at Vienna’s General Hospital, President of the Austrian Breast & Colorectal Cancer Study Group (ABCSG) and Deputy Head of the Comprehensive Cancer Center (CCC; Medical University of Vienna/Vienna General Hospital). 65 treatment centers throughout Austria with a total of 3,425 postmenopausal breast cancer patients took part in the study.

Several years ago, it was already demonstrated that osteoporosis drugs from the class of bisphosphonates can prevent a good percentage of therapy-related bone atrophy. At the same time, use of these drugs can also reduce the rate of recurrence for mammary carcinoma patients.

A meta-analysis of existing data (“The Lancet“) published by Gnant and other authors in July 2015 after a large scale study clearly demonstrated this additional effect. The frequency of bone fractures was reduced by 50 percent. The bone density enhancing anti-osteoporosis therapy led to a 28 percent reduction in bone metastases and an 18 percent decline in the long-term breast cancer mortality rate.     

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • China International Fair for Investment & Trade

    08.09. - 11.09. 2020, Xiamen, China

  • Finanzgipfel 2020

    17.09.2020/ 08:00 , Frankfurt, Deutschland

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

Novartis extends penicillin production in Tyrol

The Swiss pharmaceutical company Novartis decides on location Austria and invests 2.5 Billion EURO into penicillin production.

“Cash or card?” - Austria, the coronavirus pandemic and the increasing trend towards cashless payment.

The number of cashless transactions in Austria has been increasing for years. This upward trend once again experienced a tremendous boost due to the coronavirus pandemic.

More news All blog posts